UK and Israel Expanded Science and Tech Partnerships
The British Ambassador toured the Oxford-Cambridge corridor to deepen research ties in genomics and biotechnology.
Updated on Sept. 20, 2026 in Biotech
Live Poll
Should nations maintain scientific and business partnerships despite significant political disagreements with foreign governments?
British Ambassador Simon Walters visited the Oxford-Cambridge Growth Corridor last week to advance collaborative research and trade under the UK's International Growth Partnerships program. The tour focused on strengthening ties with Israel in genomics, biotechnology, and clean technology through meetings with academics, investors, and business leaders.
Why it matters
This partnership aims to integrate Israeli innovation with the UK’s existing research infrastructure to drive economic growth. The visit highlights a strategic shift toward deepening bilateral investment in highly specialized technical fields like artificial intelligence and advanced manufacturing.
The delegation engaged with research and business entities across the Oxford-Cambridge Growth Corridor to assess integration opportunities in AI and biotech. The visit established a roadmap for research-led collaboration across sectors compared to the previous bilateral baseline.
The players
Simon Walters
British Ambassador to Israel who is leading initiatives to foster bilateral technological and scientific cooperation.
AstraZeneca
A global pharmaceutical company with a significant research and development hub in Cambridge focusing on oncology and genomics.
Modcon Systems Ltd
A developer of advanced process analytical technology and process control systems for the petrochemical and pharmaceutical industries.
UK-Israel Tech Hub
An organization dedicated to fostering partnerships between Israeli tech firms and the United Kingdom’s innovation ecosystem.
British Council
The United Kingdom's international organization for cultural relations and educational opportunities that supports research exchange.
The details
The delegation met with leadership at AstraZeneca’s Cambridge headquarters and visited the facility of Modcon Systems Ltd, a developer of advanced process analytical technology. Discussions focused on scaling research in genomics and clean technology, leveraging the existing academic and entrepreneurial density of the Oxford-Cambridge corridor. These sessions involved stakeholders from the UK-Israel Tech Hub and the British Council, aimed at aligning commercial innovation pipelines with academic research cycles.
Timeline
September 13-19, 2026: Ambassador Walters toured the Oxford-Cambridge corridor.
The Tech Race
This collaboration follows the model of the UK government's International Growth Partnerships program to pair national strengths with regional research hubs. The effort marks an attempt to accelerate the commercialization of genomics and biotech research by integrating Israeli technical expertise.
For researchers and entrepreneurs in the Oxford-Cambridge corridor, this partnership opens potential new channels for cross-border funding and data sharing. The development is currently limited to high-level strategic alignment, with practical impacts on specific commercial products yet to be realized.
The takeaway
The visit signals an intent to bridge the innovation gap between Israeli startups and the UK’s research-heavy academic clusters. Observers should monitor the official announcements from the UK-Israel Tech Hub regarding new project funding or joint research grants emerging from this visit.
Further reading
Learn more about the latest developments in international research collaboration at Biotech.
Source note: This article includes information reported by Ynetnews.
Live Poll
Should nations maintain scientific and business partnerships despite significant political disagreements with foreign governments?
